A. Azzedine
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 6
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
- Pancreatic and Hepatic Oncology Research 2
-
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Olivier Bouché (6 shared papers)Laurent Bedenne (4 shared papers)Pascal Hammel (4 shared papers)Thomas Aparicio (4 shared papers)Laurent Mineur (3 shared papers)C. Mariette (2 shared papers)Noël Stremsdoerfer (2 shared papers)F. Mornex (2 shared papers)
In The Last Decade
A. Azzedine
8 papers receiving 957 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 733
- Gastroenterology 85
- Cancer Research 214
- Pulmonary and Respiratory Medicine 422
- Hepatology 84
Countries citing papers authored by A. Azzedine
This map shows the geographic impact of A. Azzedine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Azzedine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Azzedine more than expected).
Fields of papers citing papers by A. Azzedine
This network shows the impact of papers produced by A. Azzedine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Azzedine. The network helps show where A. Azzedine may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Azzedine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study Hit paper breakdown → | 2008 | 501 |
| 2 | 2014 | 170 | |
| 3 | 2006 | 148 | |
| 4 | 2011 | 114 | |
| 5 | 2008 | 18 | |
| 6 | 2011 | 14 | |
| 7 | 2018 | 5 | |
| 8 | 2019 | 2 |
About A. Azzedine
A. Azzedine is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Gastroenterology and Molecular Biology, having authored 8 papers that have together received 972 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Gastric Cancer Management and Outcomes (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Oncology (733 citations), Gastroenterology (85 citations), Cancer Research (214 citations), Pulmonary and Respiratory Medicine (422 citations) and Hepatology (84 citations). A. Azzedine has collaborated with scholars based in France and Belgium. Frequent co-authors include Olivier Bouché, Laurent Bedenne, Pascal Hammel, Thomas Aparicio, Laurent Mineur, C. Mariette, Noël Stremsdoerfer, F. Mornex, J.-F. Bosset and J Butel. Their work appears in journals such as Journal of Clinical Oncology, Gastric Cancer, Annals of Oncology, The Lancet Oncology and Clinical and Experimental Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.